Status:
COMPLETED
Prognostic Value of Respiratory System Compliance Under VV-ECMO on 180-day Mortality in COVID-19 ARDS.
Lead Sponsor:
Central Hospital, Nancy, France
Conditions:
Ards
Mechanical Ventilation Pressure High
Eligibility:
All Genders
18+ years
Brief Summary
Mortality of patients with COVID-19 associated acute respiratory distress syndrome (CARDS) treated with veno-venous extra-corporal membrane oxygenation (vv-ECMO) is increasing over time since the begi...
Eligibility Criteria
Inclusion
- Patients with ARDS secondary to COVID-19 pneumonia requiring ECMO-VV support, hospitalized in the intensive care units of the CHRU of Nancy, Marseille or Bordeaux between 01/03/2020 and 31/12/2021.
- Age \> 18 years old
Exclusion
- Respiratory parameters not available on ten first day of VV ECMO implantation.
- Patient refusal to participate in the study
Key Trial Info
Start Date :
January 3 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2023
Estimated Enrollment :
122 Patients enrolled
Trial Details
Trial ID
NCT05341687
Start Date
January 3 2020
End Date
May 1 2023
Last Update
July 17 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Nancy
Nancy, France